GOLDSTEIN DOV A MD
SEC insider (Form 3/4/5 filer). CIK 0001120478. Director at Gain Therapeutics, Inc. (GANX) and 2 other issuers. 17 reported Form 4/5 transactions since Sep 2024; latest on Jul 15, 2026. Located in BETHESDA, MD.
Companies GOLDSTEIN DOV A MD has filed insider reports for
- Gain Therapeutics, Inc. (GANX): Director
- BioAge Labs, Inc. (BIOA): Officer, Chief Financial Officer
- Coya Therapeutics, Inc. (COYA): Director
GOLDSTEIN DOV A MD
CIK: 0001120478
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (17 total)
- Jul 15, 2026GANX
Gain Therapeutics, Inc.
AwardDirectStock Option (right to buy)
25K shares- - Apr 23, 2026BIOA
BioAge Labs, Inc.
ExerciseDirect3.5K shares at avg. $4.38$16K - Mar 1, 2026BIOA
BioAge Labs, Inc.
ExerciseDirect3.5K shares at avg. $4.38$16K - Feb 17, 2026BIOA
BioAge Labs, Inc.
AwardDirectStock Option (Right to Buy)
110K shares- - Feb 1, 2026BIOA
BioAge Labs, Inc.
ExerciseDirect3.5K shares at avg. $4.38$16K - Jan 16, 2026BIOA
BioAge Labs, Inc.
ExerciseDirect3.5K shares at avg. $4.38$16K - Jan 13, 2026BIOA
BioAge Labs, Inc.
SaleDirect9K shares at avg. $18.43$165K - Jan 13, 2026BIOA
BioAge Labs, Inc.
SaleDirect4.4K shares at avg. $19.45$86K - Jan 13, 2026BIOA
BioAge Labs, Inc.
SaleDirect11.7K shares at avg. $20.54$240K - Jan 13, 2026BIOA
BioAge Labs, Inc.
SaleDirect1.9K shares at avg. $21.08$41K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 15, 2026 |  GANX Gain Therapeutics, Inc. | Award Stock Option (right to buy) | 25,000 | - | - | Direct |
| Apr 23, 2026 |  BIOA BioAge Labs, Inc. | Exercise | 3,542 | $4.38 | $15,514 | Direct |
| Mar 1, 2026 | BIOA BioAge Labs, Inc. | Exercise | 3,542 | $4.38 | $15,514 | Direct |
| Feb 17, 2026 | BIOA BioAge Labs, Inc. | Award Stock Option (Right to Buy) | 110,000 | - | - | Direct |
| Feb 1, 2026 | BIOA BioAge Labs, Inc. | Exercise | 3,541 | $4.38 | $15,510 | Direct |
| Jan 16, 2026 | BIOA BioAge Labs, Inc. | Exercise | 3,542 | $4.38 | $15,514 | Direct |
| Jan 13, 2026 | BIOA BioAge Labs, Inc. | Sale | 8,974 | $18.43 | $165,371 | Direct |
| Jan 13, 2026 | BIOA BioAge Labs, Inc. | Sale | 4,440 | $19.45 | $86,370 | Direct |
| Jan 13, 2026 | BIOA BioAge Labs, Inc. | Sale | 11,663 | $20.54 | $239,549 | Direct |
| Jan 13, 2026 | BIOA BioAge Labs, Inc. | Sale | 1,923 | $21.08 | $40,538 | Direct |
1-10 of 17 transactions